D B Allison|S Heshka|D Sepulveda|S B Heymsfield - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

D B Allison

S Heshka

D Sepulveda

S B Heymsfield

JAMA

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

JAMA|September 22, 1993

Counting calories--caveat emptorD B Allison, S Heshka, D Sepulveda, et al.

JAMA|November 20, 1998

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trialS B Heymsfield, D B Allison, J R Vasselli, et al.

JAMA|November 5, 1999

Annual deaths attributable to obesity in the United StatesD B Allison, K R Fontaine, J E Manson, et al.

JAMA|November 5, 1999

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trialS B Heymsfield, A S Greenberg, K Fujioka, et al.

JAMA|January 26, 1999

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trialM H Davidson, J Hauptman, M DiGirolamo, et al.

Pageof 1

Search research articles

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

JAMA|September 22, 1993

Counting calories--caveat emptorD B Allison, S Heshka, D Sepulveda, et al.

JAMA|November 20, 1998

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trialS B Heymsfield, D B Allison, J R Vasselli, et al.

JAMA|November 5, 1999

Annual deaths attributable to obesity in the United StatesD B Allison, K R Fontaine, J E Manson, et al.

JAMA|November 5, 1999

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trialS B Heymsfield, A S Greenberg, K Fujioka, et al.

JAMA|January 26, 1999

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trialM H Davidson, J Hauptman, M DiGirolamo, et al.

Pageof 1